![Inhalable siRNA Nanoparticles for Enhanced Tumor-Targeting Treatment of KRAS-Mutant Non-Small-Cell Lung Cancer | ACS Applied Materials & Interfaces Inhalable siRNA Nanoparticles for Enhanced Tumor-Targeting Treatment of KRAS-Mutant Non-Small-Cell Lung Cancer | ACS Applied Materials & Interfaces](https://pubs.acs.org/cms/10.1021/acsami.3c05007/asset/images/large/am3c05007_0007.jpeg)
Inhalable siRNA Nanoparticles for Enhanced Tumor-Targeting Treatment of KRAS-Mutant Non-Small-Cell Lung Cancer | ACS Applied Materials & Interfaces
![Cancers | Free Full-Text | The Position of Inhaled Chemotherapy in the Care of Patients with Lung Tumors: Clinical Feasibility and Indications According to Recent Pharmaceutical Progresses Cancers | Free Full-Text | The Position of Inhaled Chemotherapy in the Care of Patients with Lung Tumors: Clinical Feasibility and Indications According to Recent Pharmaceutical Progresses](https://pub.mdpi-res.com/cancers/cancers-11-00329/article_deploy/html/images/cancers-11-00329-g001.png?1571198099)
Cancers | Free Full-Text | The Position of Inhaled Chemotherapy in the Care of Patients with Lung Tumors: Clinical Feasibility and Indications According to Recent Pharmaceutical Progresses
![Inhaled dry powder cisplatin increases antitumour response to anti-PD1 in a murine lung cancer model - ScienceDirect Inhaled dry powder cisplatin increases antitumour response to anti-PD1 in a murine lung cancer model - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168365922008094-ga1.jpg)
Inhaled dry powder cisplatin increases antitumour response to anti-PD1 in a murine lung cancer model - ScienceDirect
![Inhalable bedaquiline-loaded cubosomes for the treatment of non-small cell lung cancer (NSCLC) - ScienceDirect Inhalable bedaquiline-loaded cubosomes for the treatment of non-small cell lung cancer (NSCLC) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378517321008528-ga1.jpg)
Inhalable bedaquiline-loaded cubosomes for the treatment of non-small cell lung cancer (NSCLC) - ScienceDirect
![Efficacy of nebulized acetylcysteine for relieving symptoms and reducing usage of expectorants in patients with radiation pneumonitis - Han - 2019 - Thoracic Cancer - Wiley Online Library Efficacy of nebulized acetylcysteine for relieving symptoms and reducing usage of expectorants in patients with radiation pneumonitis - Han - 2019 - Thoracic Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ac10f105-5e85-4ddb-ae22-f918b2b9fdbd/tca.2019.10.issue-2.cover.jpg?trick=1698706761427)
Efficacy of nebulized acetylcysteine for relieving symptoms and reducing usage of expectorants in patients with radiation pneumonitis - Han - 2019 - Thoracic Cancer - Wiley Online Library
![Inhalation delivery of repurposed drugs for lung cancer: Approaches, benefits and challenges - ScienceDirect Inhalation delivery of repurposed drugs for lung cancer: Approaches, benefits and challenges - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168365921006106-ga1.jpg)
Inhalation delivery of repurposed drugs for lung cancer: Approaches, benefits and challenges - ScienceDirect
![IJMS | Free Full-Text | Vectors for Inhaled Gene Therapy in Lung Cancer. Application for Nano Oncology and Safety of Bio Nanotechnology IJMS | Free Full-Text | Vectors for Inhaled Gene Therapy in Lung Cancer. Application for Nano Oncology and Safety of Bio Nanotechnology](https://www.mdpi.com/ijms/ijms-13-10828/article_deploy/html/images/ijms-13-10828f1.png)
IJMS | Free Full-Text | Vectors for Inhaled Gene Therapy in Lung Cancer. Application for Nano Oncology and Safety of Bio Nanotechnology
![Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance | PNAS Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance | PNAS](https://www.pnas.org/cms/10.1073/pnas.1004604107/asset/0942567d-1c1e-41f6-934e-3ff101f44914/assets/graphic/pnas.1004604107fig02.jpeg)
Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance | PNAS
![Pharmaceutics | Free Full-Text | Lipid-Based Inhalable Micro- and Nanocarriers of Active Agents for Treating Non-Small-Cell Lung Cancer Pharmaceutics | Free Full-Text | Lipid-Based Inhalable Micro- and Nanocarriers of Active Agents for Treating Non-Small-Cell Lung Cancer](https://www.mdpi.com/pharmaceutics/pharmaceutics-15-01457/article_deploy/html/images/pharmaceutics-15-01457-g001.png)
Pharmaceutics | Free Full-Text | Lipid-Based Inhalable Micro- and Nanocarriers of Active Agents for Treating Non-Small-Cell Lung Cancer
![Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer | Future Oncology Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon.13.67/asset/images/medium/figure2.gif)
Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer | Future Oncology
![Pulmonary delivery of osimertinib liposomes for non-small cell lung cancer treatment: formulation development and in vitro evaluation | Drug Delivery and Translational Research Pulmonary delivery of osimertinib liposomes for non-small cell lung cancer treatment: formulation development and in vitro evaluation | Drug Delivery and Translational Research](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs13346-021-01088-0/MediaObjects/13346_2021_1088_Figa_HTML.png)
Pulmonary delivery of osimertinib liposomes for non-small cell lung cancer treatment: formulation development and in vitro evaluation | Drug Delivery and Translational Research
![Inhalable sensors could enable early lung cancer detection | MIT News | Massachusetts Institute of Technology Inhalable sensors could enable early lung cancer detection | MIT News | Massachusetts Institute of Technology](https://news.mit.edu/sites/default/files/images/202401/MIT_Lung-Cancer-Diagnostics-01-PRESS.jpg)